ArticleGenes, chromosomes & cancer2022

Successful treatment with MEK-inhibitor in a patient with NRAS-related cutaneous skeletal hypophosphatemia syndrome.

Diana Carli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.